About AInnovia
We are pioneering the future of autoimmune disease detection through Machine Learning
Early, accurate diagnosis accessible to everyone, everywhere
Our Mission
To democratize access to Machine Learning-powered autoimmune disease diagnostic tools across the globe, enabling early detection that saves lives and improves patient outcomes.
Autoimmune diseases affect 1 in 10 people worldwide and have become significantly more prevalent after COVID-19. Yet, healthcare channels for these diseases are not available in semi-urban and rural areas, creating a critical gap in healthcare access.
Our Vision
A world where autoimmune diseases are detected early and accurately, regardless of geographic location or economic status, through the power of Machine Learning.
Our Core Values
These values guide everything we do, from product development to patient care.
Patient-Centric
Every decision we make is guided by our commitment to improving patient outcomes and saving lives through early detection.
Innovation
We continuously push the boundaries of AI and medical technology to create breakthrough solutions for healthcare challenges.
Accuracy
We maintain the highest standards of diagnostic accuracy, ensuring reliable results that healthcare professionals can trust.
Accessibility
We believe healthcare should be accessible to everyone, regardless of geographic location or economic status.
Our Journey
From inception to market-ready solution, here's how we're revolutionizing autoimmune disease detection.
Company Formation
AInnovia was founded with a mission to democratize autoimmune disease detection
Product Prototype
Developed ML-powered prototype achieving 95% concordance with expert pathologists
Data Banking
Built comprehensive ANA-IFA image database with expert annotations
Market Ready
Preparing for regulatory approval and commercial deployment